(Sharecast News) - The Financial Mail on Sunday's Midas column labelled shares of Oxford Instruments a "long-term buy".
First, the company's kit was helping in the discovery of new drugs and to make scientific discoveries.

Midas also called attention to Oxford's specialisation on cryostats, the tools that allow manufacturers to...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE